IMMUNE REGULATION OF EPSTEIN-BARR-VIRUS (EBV) - EBV NUCLEAR ANTIGEN AS A TARGET FOR EBV-SPECIFIC T-CELL LYSIS

被引：0
|
作者：
MOSS, DJ
MISKO, IS
SCULLEY, TB
APOLLONI, A
KHANNA, R
BURROWS, SR
机构：
来源：
SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 1991年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：147 / 156
页数：10
相关论文
共 50 条
  • [21] Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation:: Relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy
    Clave, E
    Agbalika, F
    Bajzik, V
    de Latour, RP
    Trillard, M
    Rabian, C
    Scieux, C
    Devergie, A
    Socié, G
    Ribaud, P
    Adès, L
    Ferry, C
    Gluckman, E
    Charron, D
    Esperou, H
    Toubert, A
    Moins-Teisserenc, H
    TRANSPLANTATION, 2004, 77 (01) : 76 - 84
  • [22] Establishment of Epstein-Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1
    Kanno, Hiroyuki
    Osada, Tomohiro
    Tateishi, Ayako
    MICROORGANISMS, 2023, 11 (11)
  • [23] EPSTEIN-BARR-VIRUS (EBV) INFECTS T-LYMPHOCYTES IN CHILDHOOD EBV-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    SU, IJ
    CHEN, RL
    KADIN, ME
    LABORATORY INVESTIGATION, 1994, 70 (01) : A122 - A122
  • [24] ANALYSIS OF THE TARGET-CELL FOR EPSTEIN-BARR-VIRUS INFECTION IN EPSTEIN-BARR-VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (EBV-AHS)
    MIZUTANI, S
    KAWAGUCHI, H
    MIYASHITA, T
    HERBST, H
    NIEDOBITEK, G
    ASADA, M
    TSUCHIDA, M
    HANADA, R
    KINOSHITA, A
    SAKURA, M
    KOBAYASHI, N
    LEUKEMIA, 1993, 7 : S93 - S97
  • [25] EPSTEIN-BARR-VIRUS (EBV) GLYCOPROTEIN GP350 EXPRESSED ON TRANSFECTED CELLS RESISTANT TO NATURAL-KILLER-CELL ACTIVITY SERVES AS A TARGET ANTIGEN FOR EBV-SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY
    KHYATTI, M
    PATEL, PC
    STEFANESCU, I
    MENEZES, J
    JOURNAL OF VIROLOGY, 1991, 65 (02) : 996 - 1001
  • [26] Memory Enriched Epstein-Barr Virus {EBV} Specific T-Cells with Broader Target Antigen Repertoire for the Treatment of EBV plus Malignancies
    Sharma, Sandhya
    Mehta, Naren
    Parikh, Kathan
    El-Ghazali, Ayea
    Woods, Mae
    Sauer, Tim
    Zhang, Huimin
    Mehta, Birju
    Torrano, Vicky
    Grilley, Bambi
    Heslop, Helen
    Rooney, Cliona
    MOLECULAR THERAPY, 2021, 29 (04) : 71 - 72
  • [27] Off-the-shelf EBV-specific T-cell Immunotherapy for EBV-associated PTLD
    O'Reilly, Maeve
    Peggs, Karl S.
    TRANSPLANTATION, 2020, 104 (10) : 1972 - 1973
  • [28] LOCAL SUPPRESSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXICITY IN BIOPSIES OF EBV-POSITIVE HODGKINS-DISEASE
    FRISAN, T
    SJOBERG, J
    DOLCETTI, R
    BOIOCCHI, M
    DE RE, V
    CARBONE, A
    BRAUTBAR, C
    BATTAT, S
    BIBERFELD, P
    ECKMAN, M
    OST, O
    CHRISTENSSON, B
    SUNDSTROM, C
    BJORKHOLM, M
    PISA, P
    MASUCCI, MG
    BLOOD, 1995, 86 (04) : 1493 - 1501
  • [29] Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines
    Rooney, CM
    Aguilar, LK
    Huls, MH
    Brenner, MK
    Heslop, HE
    EPSTEIN-BARR VIRUS AND HUMAN CANCER, 2001, 258 : 221 - 229
  • [30] EPSTEIN-BARR-VIRUS (EBV) TRANSFORMED B-CELL LINES AS ANTIGEN PRESENTING CELLS (APC) IN T-CELL ACTIVATION ASSAYS
    ENDLERJOBST, B
    MELMS, A
    WEKERLE, H
    IMMUNOBIOLOGY, 1987, 175 (04) : 339 - 340
12345